Dimensional Fund Advisors’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $617K | Sell |
431,888
-82,267
| -16% | -$118K | ﹤0.01% | 2957 |
|
|
2025
Q1 | $823K | Sell |
514,155
-9,776
| -2% | -$15.7K | ﹤0.01% | 2913 |
|
|
2024
Q4 | $1.89M | Sell |
523,931
-54,954
| -9% | -$198K | ﹤0.01% | 2801 |
|
|
2024
Q3 | $3.3M | Sell |
578,885
-40,227
| -6% | -$229K | ﹤0.01% | 2655 |
|
|
2024
Q2 | $2.86M | Sell |
619,112
-12,979
| -2% | -$60K | ﹤0.01% | 2667 |
|
|
2024
Q1 | $5.16M | Buy |
632,091
+516,583
| +447% | +$4.22M | ﹤0.01% | 2538 |
|
|
2023
Q4 | $654K | Sell |
115,508
-67,117
| -37% | -$380K | ﹤0.01% | 3000 |
|
|
2023
Q3 | $340K | Sell |
182,625
-80,759
| -31% | -$150K | ﹤0.01% | 3115 |
|
|
2023
Q2 | $724K | Sell |
263,384
-118,832
| -31% | -$327K | ﹤0.01% | 2991 |
|
|
2023
Q1 | $1.2M | Buy |
382,216
+2,434
| +0.6% | +$7.64K | ﹤0.01% | 2864 |
|
|
2022
Q4 | $2.24K | Buy |
379,782
+353,704
| +1,356% | +$2.09K | ﹤0.01% | 2695 |
|
|
2022
Q3 | $229K | Buy |
+26,078
| New | +$229K | ﹤0.01% | 3212 |
|